Dow Jones Today Reacting to Latest Fed Rate Hike

The Dow Jones today is trying to rebound from a Wednesday rout that followed the unsurprising decision by the U.S. Federal Reserve to raise interest rates.

Investors remain extremely grim about the prospects of the Fed's plans to hike rates two more times in 2019. The hike comes at a time when the central bank reduced its growth estimates for the U.S. economy.

The Fed also indicated that it will continue to reduce its balance sheet, despite the prospects of lower economic growth.

Here are the numbers from Wednesday for the Dow, S&P 500, and Nasdaq:

Now here's a closer look at today's most important market events and stocks, plus Thursday's economic calendar.

The Top Stock Market Stories for Thursday

• Did Fed Chair Jerome Powell use a rate hike to stick it to U.S. President Donald Trump? Some economists (like yours truly) argue that Powell was set to raise rates in December despite criticism from President Trump. However, the central bank has made it a point that it remains independent from the whims of the executive branch. Fed Chair Powell signaled that his team plans to raise interest rates at least two more times next year. However, the Fed's projection of lower economic growth is especially concerning, as earnings reports over the next two quarters could trigger further declines in the stock market. The euphoria is over.

• While the Dow Jones settles to a 2018 low, U.S. oil prices fell another 3% on concerns about global oversupply. The WTI oil price fell to as low as $45.62 this morning, the lowest level of 2018. Ongoing concerns about rising interest rates, a stronger U.S. dollar, and higher U.S. shale and Russian output continue to rattle the market. The sudden drop in recent months could trigger debt problems for U.S. and foreign producers who had expected oil prices to remain well above $80 for the balance of 2019.

Billions Are Now in Play: Millions of Americans could collect "Federal Rent Checks" - to learn how to claim your portion of an $11.1 billion money pool using this backdoor investment, click here now...

• A busy day of earnings reports will be highlighted by Nike Inc. (NYSE: NKE). This will be the company's first full quarterly report since it hired former NFL quarterback and social activist Colin Kaepernick to a major marketing campaign. Shares of Nike stock are facing bear market territory after falling nearly 20% since an all-time high set on Sept. 21.

Money Morning Insight of the Day

Do you want to know how the "Smart Money" gets rich and stays rich? They do so by using wealth tactics that maximize their investment income potential and ensure decades of wealth that can span generations. And these secrets have been locked up since the end of World War II.

Well, Money Morning Special Situation Strategist Tim Melvin has broken these secrets out of the vault of the Smart Money managers. And he's sharing the Max Wealth secrets for free right here.

Stocks to Watch Today:

• In deal news, Altria Group Inc. (NYSE: MO) has taken a 35% stake (or $12.8 billion) in e-cigarette giant Juul. The news comes just weeks after the tobacco giant took a 45% stake in cannabis producer Cronos Group Inc. (NYSE: CRON). Juul, which comprises roughly 75% of the e-cigarette market, now holds a valuation of roughly $38 billion. Shares of MO stock added 0.7% in pre-market hours.
• Shares of Walgreens Boots Alliance Inc. (NYSE: WBA) slumped nearly 2% in pre-market hours despite news that the health benefits company topped Wall Street earnings and revenue expectations. The firm reported earnings per share of $1.46, topping consensus forecasts by $0.03. The company also announced plans to slash costs by roughly $1 billion. However, no company can escape the Fed's recent forecast for lower growth in 2019.
• Speaking of Walgreens, Alphabet Inc. (NASDAQ: GOOGL) announced that its Verily unit will be partnering with the health benefits firm on several projects aimed to reduce healthcare costs and improve patient treatment. The primary focus for the two companies will center on medication adherence - or ensuring that patients take their medications as prescribed. Failure to adhere to medication guidelines costs the U.S. healthcare system a whopping $100 billion to $289 billion per year.
• Look for earnings reports from Accenture Plc. (NYSE: ACN), BlackBerry Ltd. (NASDAQ: BB), and ConAgra Brands Inc. (NYSE: CAG).

Millions of Americans Now Entitled to Collect "Federal Rent Checks"

Forty-six years ago, Congress passed an obscure piece of legislation known as Public Law 92-313. And today, it's why the Treasury is sitting on top of an $11.1 billion pile of money.

Fortunately, Americans from coast to coast have discovered a loophole that entitles them to a sizable portion of this cash.

And they're racing to add their names to a special distribution list.

Some are now receiving monthly checks worth $1,795 each. Others are collecting $3,000, $5,000, or more every month. If you want to join them in this powerful investment income stream, you better hurry up.

Because this cash is getting scooped up left and right! Read more...

Follow Money Morning on Facebook, Twitter, and LinkedIn.

Garrett Baldwin

About the Author

Browse Garrett's articles | View Garrett's research services

Garrett Baldwin is a globally recognized research economist, financial writer, and consultant with degrees from Northwestern, Johns Hopkins, Purdue, and Indiana University. He is a seasoned financial and political risk analyst, with a focus on stocks, hedge funds, private equity, blockchain, and housing policy. He has conducted risk assessment projects for clients in 27 countries, and consulted on policy and financial operations for some of the nation's largest financial institutions, including a $1.5 trillion credit fund, a $43 billion credit and auto loan giant, as well as two of the largest Wall Street banks by assets under management.

Garrett joined Money Map Press as an economist and researcher in 2011, specializing in alternative strategies with an emphasis on fundamental and technical analysis.

… Read full bio